Have you read these stories?

Johnson & Johnson starts phase 3 vaccine trial

US drugmaker Johnson & Johnson says the vaccine could be available for use by early 2021 if proven safe, effective. In the next phase ...
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 04:07 AM IST | E-Paper
Search
+

    SEARCHED FOR:GLOBAL HEADWINDS

    Bond world on high alert after rallying to historical extremes

    The warning signs go beyond this week’s failed German 30-year bond auction.

    July M&A value dips 52.7 per cent to USD 4.3 billion amid global trade tensions: Report

    According to Grant Thornton's monthly M&A Dealtracker...

    Investor optimism on global oil prices wanes

    Hedge funds' net-bullish position on Brent crude has plunged 49 per cent since early April.

    Load More...
    x
    The Economic Times